{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:34:06Z","timestamp":1792704846232,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"DOI":"10.1038\/s44276-025-00152-3","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:50:11Z","timestamp":1747734611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes"],"prefix":"10.1038","volume":"3","author":[{"given":"Marit Otterlei","family":"Fj\u00f8rtoft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Garred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Christian","family":"Lingj\u00e6rde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin Teien","family":"Lande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ottestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Riise","family":"Bergheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"OSBREAC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Naume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine Kleivi","family":"Sahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Borgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"B\u00f8rresen-Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Engebr\u00e5ten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Fritzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gry Aarum","family":"Geitvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"Hofvind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vessela N.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"K\u00e5resen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Langer\u00f8d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild Mari","family":"M\u00e6landsmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege G.","family":"Russnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torill","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Kristine","family":"Skjerven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Schlichting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"S\u00f8rlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"L\u00f8mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"LaMont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Helen","family":"Myklebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Russnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanutte","family":"Huse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0821-0585","authenticated-orcid":false,"given":"Inga Hansine","family":"Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"152_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"152_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/0971-5916.191761","volume":"143","author":"A Chakraborty","year":"2016","unstructured":"Chakraborty A, Bose CK, Basak J, Sen AN, Mishra R, Mukhopadhyay A. Determinants of lymph node status in women with breast cancer: a hospital based study from Eastern India. Indian J Med Res. 2016;143:45\u201351.","journal-title":"Indian J Med Res"},{"key":"152_CR3","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1245\/s10434-018-6486-6","volume":"25","author":"AE Giuliano","year":"2018","unstructured":"Giuliano AE, Edge SB, Hortobagyi GN. Eighth edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol. 2018;25:1783\u20135.","journal-title":"Ann Surg Oncol"},{"key":"152_CR4","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","volume":"2","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Adams S, Disis ML, Stranton S, Adams, SD LM. Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes a systematic review. JAMA Oncol. 2016;2:1354\u201360.","journal-title":"JAMA Oncol"},{"key":"152_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C, von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19:40\u201350.","journal-title":"Lancet Oncol"},{"key":"152_CR6","doi-asserted-by":"crossref","unstructured":"Dieci MV, Tsvetkova V, Orvieto E, Piacentini F, Ficarra G, Griguolo G, et al. Immune characterization of breast cancer metastases: prognostic implications. Breast Cancer Res. 2018;20:62.","DOI":"10.1186\/s13058-018-1003-1"},{"key":"152_CR7","doi-asserted-by":"crossref","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILS) in breast cancer: recommendations by an International TILS Working Group 2014. Ann Oncol. 2015;26:259\u201371.","DOI":"10.1093\/annonc\/mdu450"},{"key":"152_CR8","doi-asserted-by":"crossref","unstructured":"Loi S, Michiels S, Salgado R, Sirtaine N, Jose V, Fumagalli D, et al. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer : results from the FinHER trial. Ann Oncol. 2014;25:1544\u201350.","DOI":"10.1093\/annonc\/mdu112"},{"key":"152_CR9","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","volume":"25","author":"HR Ali","year":"2014","unstructured":"Ali HR, Provenzano E, Dawson SJ, Blows FM, Liu B, Shah M, et al. Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients. Ann Oncol. 2014;25:1536\u201343.","journal-title":"Ann Oncol"},{"key":"152_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-020-05771-7","volume":"183","author":"C Criscitiello","year":"2020","unstructured":"Criscitiello C, Vingiani A, Maisonneuve P, Viale G, Viale G, Curigliano G. Tumor-infiltrating lymphocytes (TILs) in ER+\/HER2\u2212 breast cancer. Breast Cancer Res Treat. 2020;183:347\u201354.","journal-title":"Breast Cancer Res Treat"},{"key":"152_CR11","doi-asserted-by":"crossref","unstructured":"Sobral-Leite M, Salomon I, Opdam M, Kruger DT, Beelen KJ, Van Der Noort V, et al. Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes. Breast Cancer Res. 2019;21:90.","DOI":"10.1186\/s13058-019-1176-2"},{"key":"152_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMoa2112651","volume":"386","author":"P Schmid","year":"2022","unstructured":"Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, K\u00fcmmel S, et al. Event-free survival with pembrolizumab in early triple-negative breast cancer. N. Engl J Med. 2022;386:556\u201367.","journal-title":"N. Engl J Med"},{"key":"152_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, McArthur H, K\u00fcmmel S, Bergh J, et al. Pembrolizumab for early triple-negative breast cancer. N. Engl J Med. 2020;382:810\u201321.","journal-title":"N. Engl J Med"},{"key":"152_CR14","unstructured":"Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial. Vol. 396, www.thelancet.com. 2020."},{"key":"152_CR15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1158\/1078-0432.CCR-23-0583","volume":"30","author":"P Vaidya","year":"2024","unstructured":"Vaidya P, Cohen EEW. Facts and hopes in neoadjuvant immunotherapy: current approvals and emerging evidence. Clin Cancer Res Am Assoc Cancer Res Inc. 2024;30:1232\u20139.","journal-title":"Clin Cancer Res Am Assoc Cancer Res Inc"},{"key":"152_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"A Giuliano","year":"2017","unstructured":"Giuliano A. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 2017;318:918.","journal-title":"JAMA"},{"key":"152_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00428-018-2495-x","volume":"474","author":"N Jang","year":"2019","unstructured":"Jang N, Choi JE, Kang SH, Bae YK. Validation of the pathological prognostic staging system proposed in the revised eighth edition of the AJCC staging manual in different molecular subtypes of breast cancer. Virchows Arch. 2019;474:193\u2013200.","journal-title":"Virchows Arch"},{"key":"152_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, et al. Critical role for CD103+\/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell. 2016;30:324\u201336.","journal-title":"Cancer Cell"},{"key":"152_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer Nat Publ Group. 2017;17:302\u201317.","journal-title":"Nat Rev Cancer Nat Publ Group"},{"key":"152_CR20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi E, Carr AJ, Plitas G, Cornish AE, Konopacki C, Prabhakaran S, et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 2018;174:1293\u20131308.e36.","journal-title":"Cell"},{"key":"152_CR21","first-page":"1330","volume":"177","author":"J Wagner","year":"2019","unstructured":"Wagner J, Rapsomaniki MA, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A single-cell atlas of the tumor and immune ecosystem of human breast. Cancer Cell 2019;177:1330\u201345.","journal-title":"Cancer Cell"},{"key":"152_CR22","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41588-022-01041-y","volume":"54","author":"E Danenberg","year":"2022","unstructured":"Danenberg E, Bardwell H, Zanotelli VRT, Provenzano E, Chin SFF, Rueda OM, et al. Breast tumor microenvironment structures are associated with genomic features and clinical outcome. Nat Genet. 2022;54:660\u20139.","journal-title":"Nat Genet"},{"key":"152_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07767-w","volume":"9","author":"Q Jia","year":"2018","unstructured":"Jia Q, Wu W, Wang Y, Alexander PB, Sun C, Gong Z, et al. Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 2018;9:1\u201310.","journal-title":"Nat Commun"},{"key":"152_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li H, van der Leun AM, Yofe I, Lubling Y, Gelbard-Solodkin D, van Akkooi ACJ, et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell 2019;176:775\u2013789.e18.","journal-title":"Cell"},{"key":"152_CR25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","volume":"169","author":"S Chevrier","year":"2017","unstructured":"Chevrier S, Levine JH, Zanotelli VRT, Silina K, Schulz D, Bacac M, et al. An immune atlas of clear cell renal cell carcinoma. Cell 2017;169:736\u2013749.e18.","journal-title":"Cell"},{"key":"152_CR26","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","volume":"169","author":"Y Lavin","year":"2017","unstructured":"Lavin Y, Kobayashi S, Leader A, Amir E ad D, Elefant N, Bigenwald C, et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 2017;169:750\u2013765.e17.","journal-title":"Cell"},{"key":"152_CR27","doi-asserted-by":"crossref","unstructured":"Chen B, Zhang G, Lai J, Xiao W, Li X, Li C, et al. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours. EBioMedicine. 2021;71:103542.","DOI":"10.1016\/j.ebiom.2021.103542"},{"key":"152_CR28","doi-asserted-by":"crossref","unstructured":"Liu T, Liu C, Yan M, Zhang L, Zhang J, Xiao M, et al. Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients. Nat Commun. 2022;13:6823.","DOI":"10.1038\/s41467-022-34581-2"},{"key":"152_CR29","doi-asserted-by":"crossref","unstructured":"Rye IH, Huse K, Josefsson SE, Kildal W, Danielsen HE, Schlichting E, et al. Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Mol Oncol. 2021;16:88\u2013103.","DOI":"10.1002\/1878-0261.13047"},{"key":"152_CR30","doi-asserted-by":"crossref","unstructured":"Rakha EA, Starczynski J, Lee AHS, Ellis IO. The updated ASCO\/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: A critical review of their implications for routine practice. Vol. 64, Histopathology. Blackwell Publishing Ltd; 2014. p. 609\u201315.","DOI":"10.1111\/his.12357"},{"key":"152_CR31","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.1182\/bloodadvances.2023010158","volume":"7","author":"I Spasevska","year":"2023","unstructured":"Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, et al. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood Adv. 2023;7:7216\u201330.","journal-title":"Blood Adv"},{"key":"152_CR32","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1038\/s41596-023-00881-0","volume":"18","author":"J Windhager","year":"2023","unstructured":"Windhager J, Zanotelli VRT, Schulz D, Meyer L, Daniel M, Bodenmiller B, et al. An end-to-end workflow for multiplexed image processing and analysis. Nat Protoc. 2023;18:3565\u2013613.","journal-title":"Nat Protoc"},{"key":"152_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41587-021-01094-0","volume":"40","author":"NF Greenwald","year":"2022","unstructured":"Greenwald NF, Miller G, Moen E, Kong A, Kagel A, Dougherty T, et al. Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning. Nat Biotechnol. 2022;40:555\u201365.","journal-title":"Nat Biotechnol"},{"key":"152_CR34","first-page":"127","volume":"377","author":"TJ Chen","year":"2014","unstructured":"Chen TJ, Kotecha N. Cytobank: Providing an analytics platform for community cytometry data analysis and collaboration. Curr Top Microbiol Immunol. 2014;377:127\u201357.","journal-title":"Curr Top Microbiol Immunol"},{"key":"152_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1137\/141000671","volume":"59","author":"J Bezanson","year":"2017","unstructured":"Bezanson J, Edelman A, Karpinski S, Shah VB. Julia: A fresh approach to numerical computing. SIAM Rev. 2017;59:65\u201398.","journal-title":"SIAM Rev"},{"key":"152_CR36","doi-asserted-by":"crossref","unstructured":"Stoltzfus CR, Filipek J, Gern BH, Olin BE, Leal JM, Wu Y, et al. CytoMAP: a spatial analysis toolbox reveals features of myeloid cell organization in lymphoid tissues. Cell Rep. 2020;31:107523.","DOI":"10.1016\/j.celrep.2020.107523"},{"key":"152_CR37","unstructured":"Steen C, Lingj\u00e6rde O. https:\/\/github.com\/cbsteen\/clustermap. 2022. Clustermap GitHub repository https:\/\/github.com\/cbsteen\/clustermap."},{"key":"152_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00428-019-02568-y","volume":"475","author":"A Glajcar","year":"2019","unstructured":"Glajcar A, Szpor J, Hodorowicz-Zaniewska D, Tyrak KE, Oko\u0144 K. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status. Virchows Arch. 2019;475:13\u201323.","journal-title":"Virchows Arch"},{"key":"152_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0983-9","volume":"14","author":"M Miyan","year":"2016","unstructured":"Miyan M, Schmidt-Mende J, Kiessling R, Poschke I, de Boniface J. Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer. J Transl Med. 2016;14:227.","journal-title":"J Transl Med"},{"key":"152_CR40","doi-asserted-by":"crossref","unstructured":"Uniken Venema WTC, Ram\u00edrez-S\u00e1nchez AD, Bigaeva E, Withoff S, Jonkers I, McIntyre RE, et al. Gut mucosa dissociation protocols influence cell type proportions and single-cell gene expression levels. Sci Rep. 2022;12:9897.","DOI":"10.1038\/s41598-022-13812-y"},{"key":"152_CR41","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ccell.2024.02.001","volume":"42","author":"AJ Radtke","year":"2024","unstructured":"Radtke AJ, Postovalova E, Varlamova A, Bagaev A, Sorokina M, Kudryashova O, et al. Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients. Cancer Cell. 2024;42:444\u2013463.e10.","journal-title":"Cancer Cell"},{"key":"152_CR42","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJMoa2211437","volume":"388","author":"SP Patel","year":"2023","unstructured":"Patel SP, Othus M, Chen Y, Wright GP, Yost KJ, Hyngstrom JR, et al. Neoadjuvant\u2013adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N. Engl J Med. 2023;388:813\u201323.","journal-title":"N. Engl J Med"},{"key":"152_CR43","doi-asserted-by":"crossref","unstructured":"Zhang J, Shi Z, Xu X, Yu Z, Mi J. The influence of microenvironment on tumor immunotherapy. Vol. 286, FEBS Journal. Blackwell Publishing Ltd; 2019. p. 4160\u201375.","DOI":"10.1111\/febs.15028"},{"key":"152_CR44","doi-asserted-by":"crossref","unstructured":"Mezheyeuski A, Backman M, Mattsson J, Mart\u00edn-Bernab\u00e9 A, Larsson C, Hrynchyk I, et al. An immune score reflecting pro-and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. EBioMedicine. 2023;88:104452.","DOI":"10.1016\/j.ebiom.2023.104452"},{"key":"152_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun AM, Thommen DS, Schumacher TN. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer Nat Res. 2020;20:218\u201332.","journal-title":"Nat Rev Cancer Nat Res"},{"key":"152_CR46","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10549-018-4796-9","volume":"170","author":"V Sopik","year":"2018","unstructured":"Sopik V, Narod SA. The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Res Treat. 2018;170:647\u201356.","journal-title":"Breast Cancer Res Treat"},{"key":"152_CR47","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim MK, Okholm TLH, Jones KB, McCarthy EE, Liu CC, Yee JL, et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell 2023;186:1127\u20131143.e18.","journal-title":"Cell"},{"key":"152_CR48","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/1055-9965.EPI-06-0080","volume":"15","author":"U Kronenwett","year":"2006","unstructured":"Kronenwett U, Ploner A, Zetterberg A, Bergh J, Hall P, Auer G, et al. Genomic instability and prognosis in breast carcinomas. Cancer Epidemiol Biomark Prev. 2006;15:1630\u20135.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"152_CR49","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/15384047.2020.1721251","volume":"21","author":"AF Correa","year":"2020","unstructured":"Correa AF, Ruth KJ, Al-Saleem T, Pei J, Dulaimi E, Kister D, et al. Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma. Cancer Biol Ther. 2020;21:424.","journal-title":"Cancer Biol Ther"},{"key":"152_CR50","doi-asserted-by":"crossref","unstructured":"Tietscher S, Wagner J, Anzeneder T, Langwieder C, Rees M, Sobottka B, et al. A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer. Nat Commun. 2023;14:98.","DOI":"10.1038\/s41467-022-35238-w"},{"key":"152_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91358-1","volume":"11","author":"T Morisaki","year":"2021","unstructured":"Morisaki T, Kubo M, Umebayashi M, Yew PY, Yoshimura S, Park JH, et al. Neoantigens elicit T cell responses in breast cancer. Sci Rep. 2021;11:13590.","journal-title":"Sci Rep"},{"key":"152_CR52","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41588-020-0687-1","volume":"52","author":"E Lakatos","year":"2020","unstructured":"Lakatos E, Williams MJ, Schenck RO, Cross WCH, Househam J, Zapata L, et al. Evolutionary dynamics of neoantigens in growing tumors. Nat Genet. 2020;52:1057.","journal-title":"Nat Genet"},{"key":"152_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17046-2","volume":"11","author":"NG N\u00fa\u00f1ez","year":"2020","unstructured":"N\u00fa\u00f1ez NG, Tosello Boari J, Ramos RN, Richer W, Cagnard N, Anderfuhren CD, et al. Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients. Nat Commun. 2020;11:1\u201315.","journal-title":"Nat Commun"},{"key":"152_CR54","doi-asserted-by":"crossref","unstructured":"Reticker-Flynn NE, Zhang W, Belk JA, Basto PA, Escalante NK, Pilarowski GOW, et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell. 2022;185:1924\u201342.e23.","DOI":"10.1016\/j.cell.2022.04.019"},{"key":"152_CR55","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-022-05425-2","volume":"611","author":"A Lomakin","year":"2022","unstructured":"Lomakin A, Svedlund J, Strell C, Gataric M, Shmatko A, Rukhovich G, et al. Spatial genomics maps the structure, nature and evolution of cancer clones. Nature 2022;611:594\u2013602.","journal-title":"Nature"},{"key":"152_CR56","doi-asserted-by":"crossref","unstructured":"Cance JC, Crozat K, Dalod M, Mattiuz R. Are conventional type 1 dendritic cells critical for protective antitomor immunity and how? Vol. 10, Frontiers in Immunology. Frontiers Media S.A.; 2019.","DOI":"10.3389\/fimmu.2019.00009"},{"key":"152_CR57","doi-asserted-by":"crossref","unstructured":"Whitney RB, Levy JG, Smith AG. Influence of tumor size and surgical resection on cell-mediated immunity in mice. EBioMedicine. 2023;53:111\u20136.","DOI":"10.1093\/jnci\/53.1.111"},{"key":"152_CR58","doi-asserted-by":"crossref","unstructured":"Yu JW, Bhattacharya S, Yanamandra N, Kilian D, Shi H, Yadavilli S, et al. Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. PLoS ONE. 2018;13.","DOI":"10.1371\/journal.pone.0206223"},{"key":"152_CR59","doi-asserted-by":"crossref","unstructured":"Kim SI, Cassella CR, Byrne KT. Tumor burden and immunotherapy: impact on immune infiltration and therapeutic outcomes. Front Immunol. 2020;11:629722.","DOI":"10.3389\/fimmu.2020.629722"},{"key":"152_CR60","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat Med. 2019;25:1251\u20139.","journal-title":"Nat Med"},{"key":"152_CR61","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1158\/2159-8290.CD-16-0577","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu J, Blake SJ, Yong MCR, Harjunp\u00e4\u00e4 H, Ngiow SF, Takeda K, et al. Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease. Cancer Discov. 2016;6:1382\u201399.","journal-title":"Cancer Discov"}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00152-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00152-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00152-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:09:14Z","timestamp":1747735754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00152-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1038\/s44276-025-00152-3","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the regional committee for research ethics (200606181-1, 538-07278a, 2009\/4935, 2016\/433). Informed consent was obtained from all participants in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}}],"article-number":"35"}}